Morgan Stanley’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.54M | Buy |
|
|||||
|
2025
Q1 | $9M | Sell |
|
|||||
|
2024
Q4 | $11.7M | Buy |
|
|||||
|
2024
Q3 | $11.2M | Buy |
|
|||||
|
2024
Q2 | $4.5M | Sell |
|
|||||
|
2024
Q1 | $6.83M | Sell |
|
|||||
|
2023
Q4 | $4.93M | Buy |
|
|||||
|
2023
Q3 | $419K | Sell |
|
|||||
|
2023
Q2 | $778K | Buy |
|
|||||
|
2023
Q1 | $429K | Buy |
|
|||||
|
2022
Q4 | $539K | Sell |
|
|||||
|
2022
Q3 | $1.03M | Buy |
|
|||||
|
2022
Q2 | $374K | Buy |
|
|||||
|
2022
Q1 | $214K | Buy |
|
|||||
|
2021
Q4 | $262K | Buy |
|
|||||
|
2021
Q3 | $14K | Buy |
|
|||||
|
2021
Q2 | $10K | Buy |
|